9th Annual Proteins and Antibodies Congress 2016 London

  • Conference Call
  • Oxford Global Con­fer­ences are proud to present the 9th Annual Pro­teins & Anti­bod­ies Con­gress, tak­ing place on April 1819, 2016 at the Novo­tel Lon­don West in Lon­don, UK. Together with the 3rd Annual Oxford Global Pep­tides Con­gress 2016 and the 4th Biosim­i­lars & Bio­bet­ters Con­gress 2016, the Pro­teins & Anti­bod­ies Con­gress forms part of Europe’s lead­ing net­work­ing and learn­ing plat­form for over 400 bio­log­ics experts. The con­fer­ence pro­gramme con­sists of world-​class keynote addresses and over 40 pre­sen­ta­tions which will offer cru­cial insights into how the biggest pharma com­pa­nies are devel­op­ing their bio­log­ics pipelines. Pre­sen­ta­tions will cover the most excit­ing advances in pro­tein expres­sion, purifi­ca­tion and anti­body ther­a­peu­tics, with an empha­sis on case stud­ies and best prac­tice sharing.

    2016 Speakers

    • Michel Awwad – Merrimack
    • Frank Comer – MedImmune
    • Tapan Das – BMS
    • Rakesh Dixit – Bio­log­ics Safety Assess­ment, MedImmune
    • Per-​Ola Freskgard – Neu­ro­science, Roche Inno­va­tion Cen­ter Basel
    • Rajiv Gan­gurde – Pro­tein Pro­duc­tion, Geno­cea Biosciences
    • Chang­shou Gao – Depart­ment of Anti­body Dis­cov­ery & Pro­tein Engi­neer­ing, Med­Im­mune LLc
    • Steve Hall – Pfizer Reg­u­la­tory Strat­egy, Pfizer World­wide Research and Development
    • Haruki Hasegawa – Ther­a­peu­tic Dis­cov­ery, Amgen
    • Guna Kan­nan – Amgen
    • Bernardo Perez-​Ramirez – Genzyme
    • Bianka Prinz – Adimab
    • Yang Shen – Eli Lilly
    • Binesh Shrestha – Novartis
    • Annelise Vuide­pot – Pro­tein Sci­ence, Immunocore
    • Mark Wil­son – Down­stream Devel­op­ment, Novar­tis Vac­cines and Diagnostics

    Agenda

    Day One will explore Anti­body Dis­cov­ery & Engi­neer­ing, and Pro­tein Expres­sion & Char­ac­ter­i­sa­tion top­ics. New to the anti­bod­ies pro­gramme this year will be a focus on novel anti­body for­mats and immuno-​oncology. Immuno-​oncology is poised to become one of the most impor­tant ther­a­peu­tic areas in the anti­bod­ies field, with many large phar­ma­ceu­ti­cal com­pa­nies launch­ing major col­lab­o­ra­tions in this space this year. Our panel of expert anti­bod­ies speak­ers will dis­cuss the press­ing sci­en­tific and strate­gic con­cerns of immuno-​oncology, includ­ing tar­get iden­ti­fi­ca­tion strate­gies, over­com­ing safety issues, the impact of check point inhibitors and bis­pecifics. Our Pro­tein Expres­sion speak­ers will be explor­ing the lat­est tools for mem­brane pro­tein expres­sion and mol­e­cule design strate­gies to enhance devel­opa­bil­ity. We will also have key academic-​led pre­sen­ta­tions to update del­e­gates about advances in pro­tein sci­ence includ­ing fold­ing, path­way engi­neer­ing and pro­tein modification.

    Day 1 Stream 1 – Anti­body Dis­cov­ery & Engineering

    • Mov­ing beyond mAbs: novel bis­pe­cific for­mats and ADCs
    • Novel ADC pay­loads and con­ju­ga­tion techniques
    • Anti­body phar­ma­co­ki­net­ics (PK) and Phar­ma­co­dy­nam­ics (PD)
    • New anti­body dis­cov­ery platforms
    • Sin­gle domain and recom­bi­nant anti­body tools

    Day 1 Stream 2 – Pro­tein Expres­sion & Characterisation

    • Emerg­ing tech­nolo­gies for pro­tein expres­sion: imag­ing tools, nan­odiscs and NMR
    • Mem­brane pro­teins as key drug tar­gets: over­com­ing purifi­ca­tion and expres­sion hurdles
    • The lat­est updates in pro­tein science:
      • pro­teomics
      • fold­ing
      • path­way engineering
      • pro­tein modification
    • Design­ing the right pro­teins: com­bat­ting cost of goods with early stage drug design

    Day Two will fea­ture high-​level dis­cus­sions about the Ther­a­peu­tic Appli­ca­tions of Anti­bod­ies, includ­ing excit­ing research into the appli­ca­tion of CAR T cell recep­tors in can­cer ther­a­pies and case stud­ies cov­er­ing the lat­est attempts to trans­port anti­bod­ies across the blood-​brain bar­rier. In our Pro­tein Purifi­ca­tion stream del­e­gates will hear about cur­rent efforts to reduce time­lines and cost of goods through auto­mated sys­tems, cell line devel­op­ment and dis­pos­able equip­ment. Del­e­gates will also hear about how large pharma is tack­ling the chal­lenge of pro­tein for­mu­la­tion and ensur­ing sta­bil­ity in phar­ma­ceu­ti­cal manufacturing.

    Day 2 Stream 1 – Ther­a­peu­tic Appli­ca­tions of Antibodies

    • Novel bis­pe­cific anti­bod­ies and their ther­a­peu­tic potential
    • Next-​generation affin­ity reagents: recom­bi­nant and engi­neered anti­bod­ies, nucleic acid aptamers
    • Immuno-​oncology: the lat­est research in tar­get­ing solid tumours
    • Alter­na­tive scaf­folds and novel anti­body formats

    Day 2 Stream 2 – Pro­tein Purifi­ca­tion & Down­stream Processing

    • Reduc­ing pro­tein pro­duc­tion time­lines with cell line devel­op­ment and novel dis­pos­able technologies
    • Obtain­ing ref­er­ence stan­dards for ther­a­peu­tic proteins
    • Pro­tein sta­bil­ity in phar­ma­ceu­ti­cal manufacturing:
      • stor­age concerns
      • extend­ing ‘shelf life’
    • Automa­tion and robot­ics to enhance processing

    Sub­mit a poster

    For atten­dees inter­ested in sub­mit­ting a poster, there are oppor­tu­ni­ties now avail­able. Your poster pre­sen­ta­tion will be located in the exhi­bi­tion room for two days along­side other posters from senior sci­en­tists work­ing in indus­try and academia.

    How to sub­mit your abstract

    We will require:

    • Poster title, Abstract (200 words or less)
    • Prin­ci­pal author, Organ­i­sa­tion, Mail­ing address
    • Email, Tele­phone, Fax
    • Addi­tional authors

    In order to secure your board space a fee of £250 plus VAT will be required. The poster should be pre­sented as A0 (841mm x 1189mm) por­trait size. To take advan­tage of this oppor­tu­nity you need to be reg­is­tered as a paid del­e­gate over the 2 days. We have lim­ited spaces avail­able, so please book soon!

    starting: ending: 19.04.2016 Location: , Category:

    Timeline

    Conference START 19.04.2016 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Shortlands 1 Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.